IP Library Granted Patent US 9,375,515
Granted Patent B2
US 9,375,515 · App. 12/409,790 · Granted Jun 28, 2016

Immobilized biologically active entities having high biological activity following mechanical manipulation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,375,515
App. No.
12/409,790
Granted
Jun 28, 2016
Kind
B2
Abstract

The present invention is directed to immobilized biologically active entities that retain significant biological activity following mechanical manipulation of a substrate material to which the entities are immobilized.

Claims (10)

1. A medical device comprising:

a medical device that is capable of being compacted and expanded;

a polymeric substrate material, wherein said polymeric substrate material is fluoropolymeric in composition;

a polymeric covering material attached to at least a portion of a surface of said substrate material;

a first plurality of heparin molecules having anti-thrombin Ill binding activity end point attached to at least a portion of said polymeric covering material; and

a composition comprising a second plurality of heparin molecules non-covalently combined with said first plurality of heparin molecules,

wherein said first plurality of heparin molecules have an anti-thrombin Ill binding activity of at least 100 picomoles anti-thrombin III per square centimeter (pmol/cm 2 ) substrate material when measured following compaction of said medical device to 50% of said medical device's original size and expansion of said medical device.

2. The medical device of claim 1 wherein said fluoropolymeric material is polytetrafluoroethylene.

3. The medical device of claim 1 , further comprising an antiproliferative agent.

4. The medical device of claim 3 wherein said antiproliferative agent is dexamethasone.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2012
From: GORE ENTERPRISE HOLDINGS, INC.
To: W. L. GORE & ASSOCIATES, INC.
Reel/Frame 027906/0508 →